Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by KTMFan387on Aug 13, 2020 8:58am

136 Views

Post# 31402247

RE:Q2 Actually not to bad

flad101 wrote: Wow. Numbers are actually not to bad. Beat analysts expectations of a .04$ loss per share. Revenues higher than expected. So maybe some potential here now. We will see how the markets react today. Glta

Agreed, I don't think this is a $1.00 stock anymore. More like $2.00 soon. Next qtr could see near $20Mil and positive EBITDA if they continue growing qtrs at +25%

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages